Core Insights - The company has launched several new products since 2025, including the Yuzhun SC801/SC801Air blood glucose meter and the Zhangyou M101/M101air blood uric acid and lipid meter, which have expanded its product application areas and target demographics [1] - The company has also upgraded existing products, such as the second generation of the San Nuo dynamic blood glucose meter and the EA-19 Pro uric acid and blood glucose meter, optimizing its product structure and industrial layout [1] - Future product launches will focus on multi-parameter monitoring and chronic disease management to meet user needs for family health [1] - In Q1 2025, the company reported revenue of 1.042 billion yuan, a year-on-year increase of 2.76%, while the net profit attributable to shareholders was 72 million yuan, a year-on-year decrease of 10.90% [1]